Modular SADA Conjugates for Targeted Delivery and Renal Clearance
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Effective delivery of therapeutic and diagnostic agents to human and animal subjects presents significant challenges, including issues with off-target interactions, non-specific binding, and inefficient clearance.
Innovation Solution
The development of modular self-assembly and disassembly (SADA) technologies, which are characterized by a SADA conjugate that forms a complex with a molecular weight greater than the threshold for renal clearance (i.e., not meet a threshold concentration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of stationary object
If the conjugate is designed to form stable multimers at the target site, then the initial serum half-life is extended, but the renal clearance efficiency is reduced
Solution Approach 1:
The conjugate employs dynamic self-assembly and disassembly properties, transitioning between monomeric and multimeric states in response to environmental conditions. The SADA domain enables the conjugate to automatically adjust its oligomeric state: forming multimers in circulation to extend half-life, then dissociating into monomers at the target site for efficient renal clearance. This dynamic behavior resolves the contradiction between extending serum half-life and maintaining clearance efficiency.
2Reliability
If the conjugate forms higher order multimeric complexes, then the binding avidity to target is increased, but the non-specific binding is reduced through dissociation to smaller states
Solution Approach 1:
The conjugate utilizes environmental parameter changes (pH, concentration, redox conditions) to control its oligomeric state. In circulation, physiological conditions promote monomeric or dimeric states that minimize non-specific binding. Upon reaching the target site, local environmental changes trigger self-assembly into higher order multimers, dramatically increasing binding avidity. This parameter-driven state transition resolves the contradiction between high binding avidity and reduced non-specific binding.
3Manufacturing precision
If the conjugate is designed with environmental-dependent multimerization, then the target site delivery is improved, but the system complexity is increased
Solution Approach 1:
The conjugate incorporates self-service through autonomous self-assembly and disassembly driven by environmental cues. The SADA domain is engineered to automatically respond to physiological parameters (pH, concentration, redox potential) without requiring external control mechanisms. This self-regulating behavior achieves precise target site delivery while avoiding the complexity of externally controlled assembly systems, resolving the contradiction between delivery precision and system complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The SADA conjugate achieves targeted delivery by forming stable multimers at the target site and rapidly dissociating into smaller units for efficient renal clearance, reducing off-target interactions and enhancing the initial serum half-life.
Implementation Method 1
modular self-assembly and disassembly (SADA) technologies
Implementation Method 2
disassemble to a smaller form under other conditions
Data Source
AI summary
The present invention relates to compositions and methods employing conjugates that include a self-assembly and disassembly (SADA) polypeptide and a binding domain. The present invention encompasses the recognition that conjugates with a SADA polypeptide have certain improved biological properties. SADA-conjugates are described, along with uses thereof (e.g., as therapeutic or diagnostic agents) and methods of manufacture.